Spots Global Cancer Trial Database for rheumatoid arthritis
Every month we try and update this database with for rheumatoid arthritis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss | NCT00094562 | Cancer Cancer Cachexia Chronic Obstruc... Chronic Heart F... Rheumatoid Arth... | Fish oil supple... | 18 Years - 90 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease | NCT02760433 | Rheumatoid Arth... | Olokizumab Placebo | 18 Years - | R-Pharm | |
| Impact of Anti-citrullinated Protein Antibody Status on Treatment Response and Treatment Persistence in Participants With Rheumatoid Arthritis (RA) Who Are Treated With Abatacept or Tumor Necrosis Factor Inhibitors in Australia | NCT03663829 | Rheumatoid Arth... | Non-Interventio... Non-Interventio... | 18 Years - 95 Years | Bristol-Myers Squibb | |
| SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. | NCT01295151 | Rheumatoid Arth... | Etanercept Abatacept Rituximab Adalimumab Certolizumab Pe... Infliximab Golimumab | 18 Years - | University of Leeds | |
| Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption | NCT00427804 | Rheumatoid Arth... Crohn's Disease | calcitriol | 18 Years - 50 Years | Atlanta VA Medical Center | |
| A Study of Safety and Effectiveness of Golimumab in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy | NCT00361335 | Rheumatoid Arth... | Golimumab Methotrexate Placebo | 18 Years - | Centocor, Inc. | |
| Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis | NCT06175338 | Rheumatoid Arth... | Rituximab MabThera® | 18 Years - 65 Years | Mabscale, LLC | |
| Etanercept in Rheumatoid Arthritis and Vascular Inflammation | NCT02109289 | Rheumatoid Arth... Vascular Inflam... | etanercept | 18 Years - 80 Years | Innovaderm Research Inc. | |
| Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer | NCT03816345 | Autoimmune Dise... Crohn Disease Dermatomyositis Hematopoietic a... Inflammatory Bo... Malignant Solid... Multiple Sclero... Psoriasis Psoriatic Arthr... Rheumatoid Arth... Sjogren Syndrom... Systemic Lupus ... Systemic Sclero... Ulcerative Coli... | Biospecimen Col... Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP) | NCT05615246 | Osteoarthritis ... Rheumatoid Arth... Oncology | 21 Years - | Exactech | ||
| PatientSpot Formerly Known as ArthritisPower | NCT03840928 | Rheumatoid Arth... Ankylosing Spon... Fibromyalgia Gout Crohn Disease Juvenile Idiopa... Lupus Erythemat... Myositis Osteoarthritis Osteoporosis Psoriasis Psoriatic Arthr... Scleroderma Dermatomyositis Inflammatory Bo... Polymyositis Axial Spondyloa... Diffuse Idiopat... Polymyalgia Rhe... Giant Cell Arte... Temporal Arteri... Wegener Relapsing Polyc... Undifferentiate... Spinal Cord Inj... Alzheimer Disea... Amyotrophic Lat... Ataxia Bell Palsy Brain Tumor Cerebral Aneury... Epilepsy Guillain-Barre ... Headache Head Injury Hydrocephalus Lumbar Disc Dis... Meningitis Multiple Sclero... Muscular Dystro... Neurocutaneous ... Parkinson Disea... Stroke Cluster Headach... Tension-Type He... Chronic Obstruc... Asthma Lung Cancer Cystic Fibrosis Sleep Apnea Eczema Alopecia Chronic Inflamm... Unstable Angina Heart Attack Heart Failure Arrythmia Valve Heart Dis... High Blood Pres... Congenital Hear... Peripheral Arte... Diabetes Chronic Liver D... Obesity | 19 Years - | Global Healthy Living Foundation | ||
| The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists | NCT00224562 | Rheumatoid Arth... Crohn's Disease Ankylosing Spon... Psoriasis | TNF-alpha antag... | 0 Years - | Assistance Publique - Hôpitaux de Paris | |
| Advanced Therapeutics in Rheumatoid Arthritis (RA) | NCT03976245 | Rheumatoid Arth... | Etanercept tofacitinib | 18 Years - | Lawson Health Research Institute | |
| Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia) | NCT01374971 | Rheumatoid Arth... | Certolizumab Pe... Arthroscopic sy... | 18 Years - | Arthritis Treatment Center, Maryland | |
| A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent | NCT02046603 | Rheumatoid Arth... | Tocilizumab DMARDs Oral Corticoste... Methotrexate | 18 Years - | Hoffmann-La Roche | |
| RHYTHM (Formerly Escape II Myocardium) | NCT01548768 | Rheumatoid Arth... | TNF inhibitors DMARDs | 18 Years - | Columbia University | |
| Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis. | NCT05379049 | Rheumatoid Arth... Inflammatory Ar... Ankylosing Spon... | Infliximab: Ada... | 18 Years - | University of Sulaimani | |
| Comparative Study of Janus Kinase (JAK) Inhibitors Vs Tumor Necrosis Factor (TNF) Inhibitors in Rheumatoid Arthritis | NCT05567380 | Rheumatoid Arth... | Observation | 18 Years - | Sohag University | |
| Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain | NCT01351805 | Autoimmune Dise... Systemic Inflam... Knee Pain Chron... Osteoarthritis Rheumatoid Arth... | Fish Oil Vitamin D placebo pill | 50 Years - | Brigham and Women's Hospital | |
| A Study of Tocilizumab (RoActemra/Actemra) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Participants With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF Biologic Agent | NCT02046603 | Rheumatoid Arth... | Tocilizumab DMARDs Oral Corticoste... Methotrexate | 18 Years - | Hoffmann-La Roche | |
| Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers | NCT02778789 | Rheumatoid Arth... | Tocilizumab TNF-alpha Inhib... | 18 Years - | University of Erlangen-Nürnberg Medical School | |
| An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent | NCT01641952 | Rheumatoid Arth... | Rituximab | 18 Years - | Hoffmann-La Roche | |
| The SPECTRA Study | NCT00537667 | Rheumatoid Arth... | anakinra anakinra and PE... | 18 Years - | Swedish Orphan Biovitrum | |
| Study of the Optimal Protocol for Methotrexate and Adalimumab Combination Therapy in Early Rheumatoid Arthritis | NCT00420927 | Rheumatoid Arth... | adalimumab methotrexate placebo | 18 Years - | Abbott | |
| Safety Study of Remsima® (Infliximab) in Rheumatoid Arthritis Patients in Jordan | NCT03348046 | Rheumatoid Arth... | Biosimilar Infl... | 18 Years - | Hikma Pharmaceuticals LLC | |
| Entecavir for Biological Agents Associated HBV Reactivation in Inflammatory Arthritis Patients | NCT01907230 | Rheumatoid Arth... Hepatitis B Rea... Exposure to Hep... | Entecavir | 20 Years - 90 Years | Taipei Veterans General Hospital, Taiwan | |
| A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents | NCT03670667 | Rheumatoid Arth... | Non-Interventio... Non-Interventio... Non-Interventio... | 18 Years - | Bristol-Myers Squibb | |
| Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity | NCT03941184 | SCAD Addison Disease Ankylosing Spon... Antiphospholipi... Celiac Disease Crohn Disease Dermatomyositis Polymyositis Guillain-Barre ... Hepatitis, Auto... Graves Disease Hashimoto Thyro... Multiple Sclero... Myasthenia Grav... Pernicious Anem... Polymyalgia Rhe... Primary Biliary... Psoriasis Rheumatoid Arth... Systemic Sclero... Sjögren Syndrom... Systemic Lupus ... Takayasu Arteri... Type 1 Diabetes... Ulcerative Coli... Uveitis Vasculitis Vitiligo Raynaud | 18 Years - 110 Years | Mayo Clinic | ||
| Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients | NCT01351480 | Rheumatoid Arth... | abatacept | 18 Years - | Arthritis & Rheumatic Disease Specialties Research | |
| Reconstitution of CD4+CD25highCD127low/-Tcell | NCT03736044 | Rheumatoid Arth... | TNF-blockers su... | 18 Years - | University Hospital of Ferrara | |
| Study to Evaluate the Safety, Tolerability and Efficacy of Tocilizumab in Participants With Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Non-Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs) and/or Anti-tumor Necrosis Factor (Anti-TNF) Therapy | NCT01362062 | Rheumatoid Arth... | Tocilizumab | 18 Years - | Hoffmann-La Roche | |
| Benefits of Injectable Abatacept Using Magnetic Resonance Imaging (MRI) in Rheumatoid Arthritis (RA) Patients | NCT01351480 | Rheumatoid Arth... | abatacept | 18 Years - | Arthritis & Rheumatic Disease Specialties Research | |
| Study, Evaluating Pharmacokinetics, Pharmacodynamics, Immunogenicity and Safety Profiles of Rituximab Compared to MabThera® in Patients With Rheumatoid Arthritis | NCT06175338 | Rheumatoid Arth... | Rituximab MabThera® | 18 Years - 65 Years | Mabscale, LLC | |
| Glucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid Arthritis | NCT03763201 | Rheumatoid Arth... | measurement of ... | 16 Years - | Benha University | |
| A Fish Oil Supplement to Maintain Body Weight in Patients With Disease-Related Weight Loss | NCT00094562 | Cancer Cancer Cachexia Chronic Obstruc... Chronic Heart F... Rheumatoid Arth... | Fish oil supple... | 18 Years - 90 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Glucocorticoid-induced Tumour Necrosis Factor Receptor Related Protein (GITR) in Rheumatoid Arthritis | NCT03763201 | Rheumatoid Arth... | measurement of ... | 16 Years - | Benha University | |
| Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia) | NCT01374971 | Rheumatoid Arth... | Certolizumab Pe... Arthroscopic sy... | 18 Years - | Arthritis Treatment Center, Maryland | |
| The SPECTRA Study | NCT00537667 | Rheumatoid Arth... | anakinra anakinra and PE... | 18 Years - | Swedish Orphan Biovitrum | |
| An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Sero-Positive Rheumatoid Arthritis Who Are Non-Responders or Intolerant to a Single TNF-Inhibitor (PORTSMAB) | NCT01309282 | Rheumatoid Arth... | 18 Years - | Hoffmann-La Roche | ||
| Exercise-induced Cardiac Adaptions in Rheumatoid Arthritis Patients During IL-6 vs. TNF Antibody Therapy | NCT05215509 | Rheumatoid Arth... | Exercise No exercise | 18 Years - 70 Years | Rigshospitalet, Denmark | |
| Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy | NCT01463059 | Rheumatoid Arth... | Placebo Olokizumab 60 m... Olokizumab 120 ... Olokizumab 240 ... | 20 Years - | UCB Pharma | |
| Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants | NCT01009879 | Rheumatoid Arth... | Etanercept | 18 Years - | University of Pittsburgh | |
| Impact of Anti-citrullinated Protein Antibody Status on Treatment Response and Treatment Persistence in Participants With Rheumatoid Arthritis (RA) Who Are Treated With Abatacept or Tumor Necrosis Factor Inhibitors in Australia | NCT03663829 | Rheumatoid Arth... | Non-Interventio... Non-Interventio... | 18 Years - 95 Years | Bristol-Myers Squibb | |
| Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) | NCT01350804 | Rheumatoid Arth... | AIN457 Placebo Abatacept | 18 Years - | Novartis | |
| Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis | NCT02862574 | Rheumatoid Arth... | Andecaliximab Placebo Methotrexate TNF Inhibitor | 18 Years - 80 Years | Gilead Sciences | |
| OTIS Autoimmune Diseases in Pregnancy Project | NCT01086059 | Crohn's Disease Rheumatoid Arth... | - | University of California, San Diego | ||
| A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea | NCT01294722 | Rheumatoid Arth... | 20 Years - | Janssen Korea, Ltd., Korea | ||
| Role of the ANS Dysregulation in the Persistence of Fatigue in Rheumatoid Arthritis Patients Treated With Anti-TNF | NCT02475486 | Rheumatoid Arth... | VistaO2 | 30 Years - 75 Years | Centre Hospitalier Universitaire de Saint Etienne | |
| Safety and Effectiveness of Adalimumab in Patients Diagnosed With Rheumatoid Arthritis | NCT01078571 | Rheumatoid Arth... | adalimumab (HUM... | 18 Years - | Abbott | |
| Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis. | NCT05379049 | Rheumatoid Arth... Inflammatory Ar... Ankylosing Spon... | Infliximab: Ada... | 18 Years - | University of Sulaimani | |
| Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World" | NCT02878161 | Rheumatoid Arth... | methotrexate(ne... infliximab etanercept adalimumab leflunomide (pe... NSAIDs (permitt... Glucocorticoids... | 18 Years - 75 Years | Central South University | |
| A Study to Determine the Number of Participants With Rheumatoid Arthritis (RA) Who Meet the Requirements for Treatment With Anti-Tumor Necrosis Factor α (TNFα) in a General Hospital Setting in Korea | NCT01294722 | Rheumatoid Arth... | 20 Years - | Janssen Korea, Ltd., Korea | ||
| Humira in Rheumatoid Arthritis - Do Bone Erosions Heal? | NCT00696059 | Rheumatoid Arth... Arthritis Joint Diseases | Adalimumab (Hum... | 18 Years - 90 Years | Hvidovre University Hospital | |
| VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid Arthritis | NCT01390545 | Rheumatoid Arth... | Veltuzumab | 18 Years - | Takeda | |
| The SPECTRA Study | NCT00537667 | Rheumatoid Arth... | anakinra anakinra and PE... | 18 Years - | Swedish Orphan Biovitrum | |
| Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease | NCT03656627 | Autoimmune Dise... Non-small Cell ... Rheumatoid Arth... Psoriasis Giant Cell Arte... Polymyalgia Rhe... Systemic Lupus ... Crohn Disease Multiple Sclero... Ulcerative Coli... | Nivolumab | 18 Years - | Alliance Foundation Trials, LLC. | |
| Prospective Study of Patients With Rheumatoid Arthritis After the Age of 65 | NCT02686320 | Rheumatoid Arth... | 18 Years - | Assistance Publique - Hôpitaux de Paris | ||
| T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade | NCT01060098 | Rheumatoid Arth... Ankylosing Spon... Psoriatic Arthr... | anti-TNF therap... | 18 Years - 80 Years | Imperial College London | |
| An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis | NCT01613027 | Rheumatoid Arth... | Rituximab | 18 Years - | Hoffmann-La Roche | |
| People-Powered Medicine (PPM): Rheumatoid Arthritis Non-responders to Biologic Therapies (RANT) | NCT05447182 | Rheumatoid Arth... | 18 Years - 95 Years | Brigham and Women's Hospital | ||
| SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug. | NCT01295151 | Rheumatoid Arth... | Etanercept Abatacept Rituximab Adalimumab Certolizumab Pe... Infliximab Golimumab | 18 Years - | University of Leeds | |
| Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB) | NCT02102594 | Myasthenia Grav... Systemic Lupus ... Rheumatoid Arth... | Bortezomib | 18 Years - 75 Years | Charite University, Berlin, Germany | |
| A Moderate to Severe Rheumatoid Arthritis Study | NCT01721044 | Rheumatoid Arth... | Placebo Baricitinib cDMARD | 18 Years - | Eli Lilly and Company | |
| Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients | NCT02116504 | Rheumatoid Arth... Juvenile Idiopa... | Sampling of blo... | 2 Years - | Assistance Publique - Hôpitaux de Paris | |
| A Study to Determine the Risk of Cancer in Rheumatoid Arthritis (RA) Patients Who Use Abatacept and Other Biologic Agents | NCT03670667 | Rheumatoid Arth... | Non-Interventio... Non-Interventio... Non-Interventio... | 18 Years - | Bristol-Myers Squibb | |
| Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid Arthritis | NCT03449758 | Rheumatoid Arth... | SARILUMAB Azathioprine Chloroquine Hydroxychloroqu... Leflunomide Methotrexate Sulfasalazine | 18 Years - | Sanofi | |
| Comparative Study of Janus Kinase (JAK) Inhibitors Vs Tumor Necrosis Factor (TNF) Inhibitors in Rheumatoid Arthritis | NCT05567380 | Rheumatoid Arth... | Observation | 18 Years - | Sohag University | |
| Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP) | NCT05615246 | Osteoarthritis ... Rheumatoid Arth... Oncology | 21 Years - | Exactech | ||
| Phase III Study of BMS-188667 (CTLA4Ig) in Patients With Rheumatoid Arthritis Who Are Currently Failing Anti-TNF Therapy or Who Have Failed Anti-TNF Therapy in the Past. | NCT00048581 | Rheumatoid Arth... | Abatacept Placebo Abatacept | 18 Years - | Bristol-Myers Squibb | |
| Pregnancy and Medically Assisted Conception in Rare Diseases | NCT02450396 | Rheumatoid Arth... Spondyloarthrit... Psoriatic Arthr... Systemic Lupus ... Antiphospholipi... Sjogren Syndrom... Scleroderma Myositis Vasculitis Mastocytosis Various Autoimm... | - | Assistance Publique - Hôpitaux de Paris | ||
| Effectiveness and Safety of Yisaipu Combined With Tripterygium Wilfordii for Active RA | NCT03589833 | Arthritis, Rheu... | Tripterygium Wi... Methotrexate Yisaipu | 18 Years - 65 Years | Peking Union Medical College Hospital | |
| Efficacy at 24 Weeks and Safety, Tolerability and Long Term Efficacy of Secukinumab (AIN457) in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Anti-Tumor Necrosis Factor α (Anti-TNFα) Agents (CAIN457F2309 and CAIN457F2309E1) | NCT01350804 | Rheumatoid Arth... | AIN457 Placebo Abatacept | 18 Years - | Novartis | |
| RHYTHM (Formerly Escape II Myocardium) | NCT01548768 | Rheumatoid Arth... | TNF inhibitors DMARDs | 18 Years - | Columbia University | |
| Abatacept and the Risk of Cancer: a Case Non-case Analysis in VigiBase | NCT03980639 | Rheumatoid Arth... | patient treated... | 18 Years - | University Hospital, Toulouse | |
| Comprehensive Segmental Revision System | NCT03270982 | Degenerative Di... Oncology Revision Surger... Trauma Rheumatoid Arth... | Comprehensive S... | - | Zimmer Biomet | |
| Tumor Necrosis Factor Decreases Vitamin D Dependant Calcium Absorption | NCT00427804 | Rheumatoid Arth... Crohn's Disease | calcitriol | 18 Years - 50 Years | Atlanta VA Medical Center | |
| Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP) | NCT05615246 | Osteoarthritis ... Rheumatoid Arth... Oncology | 21 Years - | Exactech | ||
| Observation of Treatment With Certolizumab Pegol in Daily Practice | NCT01069419 | Rheumatoid Arth... | 18 Years - | UCB Pharma | ||
| Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo, in Subjects With Rheumatoid Arthritis (RA) Who Were Taking an Existing Medication Called a Tumour Necrosis Factor Alpha Inhibitor But Had Active Disease | NCT02760433 | Rheumatoid Arth... | Olokizumab Placebo | 18 Years - | R-Pharm | |
| A Post-marketing Study to Assess the Safety of Abatacept in Sweden Using the Swedish Rheumatology Quality Register (SRQ) Register | NCT05413044 | Rheumatoid Arth... Psoriatic Arthr... | 18 Years - | Bristol-Myers Squibb |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
